(Q39551849)

13 September 2017

1 reference

title

Therapeutic strategies with monoclonal antibodies and immunoconjugates (English)

1 reference

13 September 2017

1 reference

Byers VS

1

1 reference

PubMed ID

3061932

13 September 2017

Baldwin RW

series ordinal

2

1 reference

13 September 2017

1 November 1988

1 reference

13 September 2017

1 reference

13 September 2017

65

1 reference

13 September 2017

3

1 reference

13 September 2017

329-335

1 reference

Endocytosis and degradation of murine anti-human CD3 monoclonal antibodies by normal and malignant T-lymphocytes

13 September 2017

1 reference

12 December 2020

Anti-idiotypic antibodies and the induction of specific tumor immunity.

1 reference

12 December 2020

Do Primary Physicians Actually Manage Their Patients' Fee-for-Service Care?

1 reference

12 December 2020

Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates

1 reference

12 December 2020

Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopes.

1 reference

12 December 2020

Phase I Trial of Multiple Large Doses of Murine Monoclonal Antibody CO17-1A. II. Pharmacokinetics and Immune Response1

1 reference

12 December 2020

The implications of patient antibody response for the clinical usefulness of immunoscintigraphy

1 reference

12 December 2020

Monoclonal antibodies and immunoconjugates for cancer treatment

1 reference

12 December 2020

Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells.

1 reference

12 December 2020

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

12 December 2020

The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients

1 reference

12 December 2020

Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinoma

1 reference

12 December 2020

Study of the plasma clearance of antibody--ricin-A-chain immunotoxins. Evidence for specific recognition sites on the A chain that mediate rapid clearance of the immunotoxin

1 reference

12 December 2020

Purification of ricin A1, A2, and B chains and characterization of their toxicity.

1 reference

12 December 2020

An improved synthesis of a methotrexate-albumin-791T/36 monoclonal antibody conjugate cytotoxic to human osteogenic sarcoma cell lines

1 reference

12 December 2020

Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression

1 reference

12 December 2020

Tolerance to rat monoclonal antibodies. Implications for serotherapy

1 reference

12 December 2020

Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system

1 reference

12 December 2020

Dosimetric aspects of radiolabeled antibodies for tumor therapy

1 reference

12 December 2020

Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: correlation with clinical responses

1 reference

12 December 2020

Immune interventions in disease

1 reference

12 December 2020

Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas

1 reference

12 December 2020

Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer

1 reference

12 December 2020

Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin

1 reference

12 December 2020

Construction and characterisation of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids.

1 reference

12 December 2020

Increased therapeutic effect of vinca alkaloids targeted to tumour by a hybrid-hybrid monoclonal antibody

1 reference

12 December 2020

Selective killing of normal and neoplastic human B cells with anti-CD19- and anti-CD22-ricin A chain immunotoxins

1 reference

12 December 2020

Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen

1 reference

12 December 2020

RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes

1 reference

12 December 2020

Human monoclonal antibody production. Current status and future prospects

1 reference

12 December 2020

Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma

1 reference

12 December 2020

Limitations to the killing of tumours using radiolabelled antibodies

1 reference

12 December 2020

Acidification of the cytosol inhibits endocytosis from coated pits

1 reference

12 December 2020

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma

1 reference

12 December 2020

Biodistribution of ricin toxin A chain-monoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents

1 reference

12 December 2020

Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A.

1 reference

12 December 2020

Comparative biodistribution of methotrexate and monoclonal antibody-methotrexate complexes in mice

1 reference

12 December 2020

Anti-idiotype immunization of cancer patients: modulation of the immune response

1 reference

12 December 2020

Redesigning nature's poisons to create anti-tumor reagents

1 reference

12 December 2020

Anti-human tumor antibodies induced in mice and rabbits by "internal image" anti-idiotypic monoclonal immunoglobulins.

1 reference

12 December 2020

Human monoclonal antibodies and monoclonal antibody multispecificity

1 reference

12 December 2020

Uptake of native and deglycosylated ricin A-chain immunotoxins by mouse liver parenchymal and non-parenchymal cells in vitro and in vivo

1 reference

12 December 2020

Reexposure to OKT3 in renal allograft recipients

1 reference

12 December 2020

Identifiers

PubMed ID

3061932

1 reference

PubMed ID

3061932